Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension
- 1 March 2018
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 37 (3), 365-375
- https://doi.org/10.1016/j.healun.2017.08.009
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Matching Methods for Causal Inference: A Review and a Look ForwardStatistical Science, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- Ambrisentan for the Treatment of Pulmonary Arterial HypertensionCirculation, 2008
- Changes in Right Ventricular Structure and Function Assessed Using Cardiac Magnetic Resonance Imaging in Bosentan-Treated Patients With Pulmonary Arterial HypertensionThe American Journal of Cardiology, 2008
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertensionJournal of the American College of Cardiology, 2003
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001